Literature DB >> 26330354

Calpain in Breast Cancer: Role in Disease Progression and Treatment Response.

Sarah J Storr1, Nicola Thompson, Xuan Pu, Yimin Zhang, Stewart G Martin.   

Abstract

The calpains are a family of intracellular cysteine proteases that function in a wide array of cellular activities, including cytoskeletal remodelling, survival and apoptosis. The ubiquitously expressed micro (µ)-calpain and milli (m)-calpain are archetypal family members that require calcium for function and can be inhibited by their endogenous inhibitor calpastatin. This review describes the role of the calpain system in the prognosis of breast cancer and disease progression, in addition to the role of the calpain system in the response to breast cancer treatments, including chemotherapeutic, endocrine and targeted therapies.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26330354     DOI: 10.1159/000430464

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  19 in total

1.  Fibronectin induces epithelial-mesenchymal transition in human breast cancer MCF-7 cells via activation of calpain.

Authors:  Cheng-Lin Li; Dan Yang; Xin Cao; Fan Wang; Duan-Yang Hong; Jing Wang; Xiang-Chun Shen; Yan Chen
Journal:  Oncol Lett       Date:  2017-03-23       Impact factor: 2.967

Review 2.  A Tale of Two States: Normal and Transformed, With and Without Rigidity Sensing.

Authors:  Michael Sheetz
Journal:  Annu Rev Cell Dev Biol       Date:  2019-08-14       Impact factor: 13.827

3.  MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients.

Authors:  Josien C Haan; Rajith Bhaskaran; Architha Ellappalayam; Yannick Bijl; Christian J Griffioen; Ersan Lujinovic; William M Audeh; Frédérique Penault-Llorca; Lorenza Mittempergher; Annuska M Glas
Journal:  Genes Chromosomes Cancer       Date:  2021-12-11       Impact factor: 4.263

4.  Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses.

Authors:  Kellie A Schaefer; Marcus A Toral; Gabriel Velez; Allison J Cox; Sheila A Baker; Nicholas C Borcherding; Diana F Colgan; Vimala Bondada; Charles B Mashburn; Chen-Guang Yu; James W Geddes; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

5.  Clinical correlation of calpain-1 and glypican-3 expression with gallbladder carcinoma.

Authors:  Weiqing Luo; Zhigang Ren; Sheng Gao; Hailong Jin; Geer Zhang; Lin Zhou; Shusen Zheng
Journal:  Oncol Lett       Date:  2016-01-07       Impact factor: 2.967

6.  The Calcium-Induced Regulation in the Molecular and Transcriptional Circuitry of Human Inflammatory Response and Autoimmunity.

Authors:  Ivo R de Seabra Rodrigues Dias; Simon W F Mok; Flora Gordillo-Martínez; Imran Khan; Wendy W L Hsiao; Betty Y K Law; Vincent K W Wong; Liang Liu
Journal:  Front Pharmacol       Date:  2018-01-08       Impact factor: 5.810

7.  Decreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC.

Authors:  Yinzhou Xiang; Fen Li; Lei Wang; Anyuan Zheng; Jingjing Zuo; Man Li; Yongping Wang; Yong Xu; Chen Chen; Shiming Chen; Bokui Xiao; Zezhang Tao
Journal:  Oncol Lett       Date:  2017-02-07       Impact factor: 2.967

8.  Calpain-1 Expression in Triple-Negative Breast Cancer: A Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index.

Authors:  Shadia M Al-Bahlani; Ruqaya M Al-Rashdi; Shiyam Kumar; Shadia S Al-Sinawi; Maiya A Al-Bahri; Asem A Shalaby
Journal:  Biomed Res Int       Date:  2017-04-27       Impact factor: 3.411

9.  New localization and function of calpain-2 in nucleoli of colorectal cancer cells in ribosomal biogenesis: effect of KRAS status.

Authors:  Marcelino Telechea-Fernández; Lucia Rodríguez-Fernández; Concha García; Rosa Zaragozá; Juan Viña; Andrés Cervantes; Elena R García-Trevijano
Journal:  Oncotarget       Date:  2018-01-03

10.  Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.

Authors:  Bao-Hua Yu; Bai-Zhou Li; Xiao-Yan Zhou; Da-Ren Shi; Wen-Tao Yang
Journal:  Diagn Pathol       Date:  2018-05-30       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.